Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
27,893 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Arm Holdings unveiled its first custom processor for agentic AI workloads, triggering a sharp stock rally and signali...
A major national poll released this week reveals broad dissatisfaction with the economy, a finding that may influence...
In a year of rapid change, Inchcape’s leadership says healthy competition is propelling the auto industry toward a co...
eXp Commercial announced the addition of Mario Alvarez Jr., a Southern California veteran with over $1B in career dea...
Tether rolled out a decentralized local AI initiative linked to its stability framework, calling it a new form of int...
Canadian travel to the United States is declining beyond leisure trips, with business travel and investor visits fall...
KeyBanc lowers its price target for On Holding AG to $43, citing tariff exposure that weighs on margins, even as the ...
Fraudsters are targeting XRPL users with fake airdrops and impersonation schemes as activity climbs. A ripple insider...
The Senate committee advanced the crypto market structure bill, signaling momentum but not guaranteed passage. Analys...
Zerohash Europe becomes the first crypto firm to hold both an EMI license and MiCA authorization, expanding stablecoi...
Bitcoin hovers around the $60,000 level as traders question the significance of the 200-day moving average. K33 sugge...